Changing the Treatment Paradigm for Type 2 Diabetes
Article Figures & Tables
Figures
- Figure 1
Percentage of type 2 diabetic patients achieving treatment targets for glucose, total cholesterol, and blood pressure in NHANES 1999–2004 (44). □, 1999; ■, 2004.
Tables
- Table 1
Barriers in achieving and maintaining glycemic control in type 2 diabetic patients
-
Ineffective diet/exercise initiatives
-
Lack of efficacy of pharmacological agents
-
Conservative management
-
Adverse events
-
Poor compliance
-
Underlying pathophysiology
-
Suboptimal health care systems
-
- Table 2
Available antidiabetic agents for treatment of type 2 diabetes
Sulfonylureas First generation Second generation Third generation Modified release Glinides Nonsulfonylureic Amino acid derivatives Biguanides Metformin Thiazolidinediones Rosiglitazone Pioglitazone Fixed-dose oral hypoglycemic agents combinations α-Glucosidase inhibitors Acarbose Voglibose Insulin Regular Long-acting Pre-mixed Insulin analogs Rapid-acting Long-acting Inhaled GLP-1 analogs Dipeptidyl peptidase-4 inhibitors Amylin analog
In this Issue
November 2009, 32(suppl 2)
